Wang S - Search Results

1

Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1.

Wang S, Arthos J, Lawrence JM, Van Ryk D, Mboudjeka I, Shen S, Chou TH, Montefiori DC, Lu S. Wang S, et al. J Virol. 2005 Jun;79(12):7933-7. doi: 10.1128/JVI.79.12.7933-7937.2005. J Virol. 2005. PMID: 15919951 Free PMC article.

2

Protection against rotavirus infections by DNA vaccination.

Herrmann JE, Chen SC, Fynan EF, Santoro JC, Greenberg HB, Wang S, Robinson HL. Herrmann JE, et al. Among authors: wang s. J Infect Dis. 1996 Sep;174 Suppl 1:S93-7. doi: 10.1093/infdis/174.supplement_1.s93. J Infect Dis. 1996. PMID: 8752297

3

Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regions.

Lu S, Wyatt R, Richmond JF, Mustafa F, Wang S, Weng J, Montefiori DC, Sodroski J, Robinson HL. Lu S, et al. Among authors: wang s. AIDS Res Hum Retroviruses. 1998 Jan 20;14(2):151-5. doi: 10.1089/aid.1998.14.151. AIDS Res Hum Retroviruses. 1998. PMID: 9462925

4

Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection.

Yang K, Wang S, Chang KO, Lu S, Saif LJ, Greenberg HB, Brinker JP, Herrmann JE. Yang K, et al. Among authors: wang s. Vaccine. 2001 Apr 30;19(23-24):3285-91. doi: 10.1016/s0264-410x(00)00543-0. Vaccine. 2001. PMID: 11312027

5

The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region.

Barnett SW, Lu S, Srivastava I, Cherpelis S, Gettie A, Blanchard J, Wang S, Mboudjeka I, Leung L, Lian Y, Fong A, Buckner C, Ly A, Hilt S, Ulmer J, Wild CT, Mascola JR, Stamatatos L. Barnett SW, et al. Among authors: wang s. J Virol. 2001 Jun;75(12):5526-40. doi: 10.1128/JVI.75.12.5526-5540.2001. J Virol. 2001. PMID: 11356960 Free PMC article.

6

Delivery of DNA to skin by particle bombardment.

Wang S, Joshi S, Lu S. Wang S, et al. Methods Mol Biol. 2004;245:185-96. doi: 10.1385/1-59259-649-5:185. Methods Mol Biol. 2004. PMID: 14707379 No abstract available.

7

Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model.

Liu F, Mboudjeka I, Shen S, Chou TH, Wang S, Ross TM, Lu S. Liu F, et al. Among authors: wang s. Vaccine. 2004 Apr 16;22(13-14):1764-72. doi: 10.1016/j.vaccine.2003.09.054. Vaccine. 2004. PMID: 15068860

8

[Immunogenicity of new DNA vaccine encoding for hepatitis B virus core antigen].

Xing YP, Huang ZH, Wang SX, Cai J, Li J, Lu S. Xing YP, et al. Among authors: wang sx. Zhonghua Gan Zang Bing Za Zhi. 2004 Jun;12(6):338-40. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15225426 Chinese.

9

A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague.

Wang S, Heilman D, Liu F, Giehl T, Joshi S, Huang X, Chou TH, Goguen J, Lu S. Wang S, et al. Vaccine. 2004 Sep 3;22(25-26):3348-57. doi: 10.1016/j.vaccine.2004.02.036. Vaccine. 2004. PMID: 15308359 Free PMC article.

10

Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system.

Wang S, Chou TH, Sakhatskyy PV, Huang S, Lawrence JM, Cao H, Huang X, Lu S. Wang S, et al. J Virol. 2005 Feb;79(3):1906-10. doi: 10.1128/JVI.79.3.1906-1910.2005. J Virol. 2005. PMID: 15650214 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118,329 results

Search Page

Filters